vs

Side-by-side financial comparison of Palomar Holdings, Inc. (PLMR) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

Palomar Holdings, Inc. is the larger business by last-quarter revenue ($253.4M vs $197.9M, roughly 1.3× REPLIGEN CORP). On growth, Palomar Holdings, Inc. posted the faster year-over-year revenue change (62.7% vs 13.6%). Palomar Holdings, Inc. produced more free cash flow last quarter ($409.0M vs $17.6M). Over the past eight quarters, Palomar Holdings, Inc.'s revenue compounded faster (46.2% CAGR vs 14.4%).

Palomar Holdings, Inc. is a specialty insurance holding company that primarily provides property insurance products for catastrophe-exposed residential and commercial assets. It mainly operates across the United States, focusing on core segments including earthquake, flood, and windstorm coverage to meet high-risk property protection demands of customers.

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

PLMR vs RGEN — Head-to-Head

Bigger by revenue
PLMR
PLMR
1.3× larger
PLMR
$253.4M
$197.9M
RGEN
Growing faster (revenue YoY)
PLMR
PLMR
+49.0% gap
PLMR
62.7%
13.6%
RGEN
More free cash flow
PLMR
PLMR
$391.4M more FCF
PLMR
$409.0M
$17.6M
RGEN
Faster 2-yr revenue CAGR
PLMR
PLMR
Annualised
PLMR
46.2%
14.4%
RGEN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PLMR
PLMR
RGEN
RGEN
Revenue
$253.4M
$197.9M
Net Profit
$13.3M
Gross Margin
52.5%
Operating Margin
28.7%
9.0%
Net Margin
6.7%
Revenue YoY
62.7%
13.6%
Net Profit YoY
143.9%
EPS (diluted)
$2.05
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PLMR
PLMR
RGEN
RGEN
Q4 25
$253.4M
$197.9M
Q3 25
$244.7M
$188.8M
Q2 25
$203.3M
$182.4M
Q1 25
$174.6M
$169.2M
Q4 24
$155.8M
$174.1M
Q3 24
$148.5M
$154.9M
Q2 24
$131.1M
$154.1M
Q1 24
$118.5M
$151.3M
Net Profit
PLMR
PLMR
RGEN
RGEN
Q4 25
$13.3M
Q3 25
$51.5M
$14.9M
Q2 25
$46.5M
$14.9M
Q1 25
$42.9M
$5.8M
Q4 24
$-30.3M
Q3 24
$30.5M
$-654.0K
Q2 24
$25.7M
$3.3M
Q1 24
$26.4M
$2.1M
Gross Margin
PLMR
PLMR
RGEN
RGEN
Q4 25
52.5%
Q3 25
53.2%
Q2 25
50.0%
Q1 25
53.6%
Q4 24
26.1%
Q3 24
50.0%
Q2 24
49.8%
Q1 24
49.5%
Operating Margin
PLMR
PLMR
RGEN
RGEN
Q4 25
28.7%
9.0%
Q3 25
27.4%
8.9%
Q2 25
29.5%
7.6%
Q1 25
30.8%
3.9%
Q4 24
28.9%
-17.7%
Q3 24
25.9%
-5.1%
Q2 24
25.5%
1.0%
Q1 24
29.0%
1.3%
Net Margin
PLMR
PLMR
RGEN
RGEN
Q4 25
6.7%
Q3 25
21.0%
7.9%
Q2 25
22.9%
8.2%
Q1 25
24.6%
3.4%
Q4 24
-17.4%
Q3 24
20.5%
-0.4%
Q2 24
19.6%
2.2%
Q1 24
22.3%
1.4%
EPS (diluted)
PLMR
PLMR
RGEN
RGEN
Q4 25
$2.05
$0.24
Q3 25
$1.87
$0.26
Q2 25
$1.68
$0.26
Q1 25
$1.57
$0.10
Q4 24
$1.29
$-0.55
Q3 24
$1.15
$-0.01
Q2 24
$1.00
$0.06
Q1 24
$1.04
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PLMR
PLMR
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$106.9M
$767.6M
Total DebtLower is stronger
$542.2M
Stockholders' EquityBook value
$942.7M
$2.1B
Total Assets
$3.1B
$2.9B
Debt / EquityLower = less leverage
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PLMR
PLMR
RGEN
RGEN
Q4 25
$106.9M
$767.6M
Q3 25
$111.7M
$748.7M
Q2 25
$81.3M
$708.9M
Q1 25
$119.3M
$697.2M
Q4 24
$80.4M
$757.4M
Q3 24
$86.5M
$784.0M
Q2 24
$47.8M
$809.1M
Q1 24
$61.4M
$780.6M
Total Debt
PLMR
PLMR
RGEN
RGEN
Q4 25
$542.2M
Q3 25
$537.9M
Q2 25
Q1 25
Q4 24
$525.6M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
PLMR
PLMR
RGEN
RGEN
Q4 25
$942.7M
$2.1B
Q3 25
$878.1M
$2.1B
Q2 25
$847.2M
$2.1B
Q1 25
$790.4M
$2.0B
Q4 24
$729.0M
$2.0B
Q3 24
$703.3M
$2.0B
Q2 24
$532.6M
$2.0B
Q1 24
$501.7M
$2.0B
Total Assets
PLMR
PLMR
RGEN
RGEN
Q4 25
$3.1B
$2.9B
Q3 25
$2.9B
$2.9B
Q2 25
$2.8B
$2.9B
Q1 25
$2.4B
$2.9B
Q4 24
$2.3B
$2.8B
Q3 24
$2.3B
$2.8B
Q2 24
$2.0B
$2.9B
Q1 24
$1.9B
$2.8B
Debt / Equity
PLMR
PLMR
RGEN
RGEN
Q4 25
0.26×
Q3 25
0.26×
Q2 25
Q1 25
Q4 24
0.27×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PLMR
PLMR
RGEN
RGEN
Operating Cash FlowLast quarter
$409.1M
$25.7M
Free Cash FlowOCF − Capex
$409.0M
$17.6M
FCF MarginFCF / Revenue
161.4%
8.9%
Capex IntensityCapex / Revenue
0.1%
4.1%
Cash ConversionOCF / Net Profit
1.93×
TTM Free Cash FlowTrailing 4 quarters
$700.6M
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PLMR
PLMR
RGEN
RGEN
Q4 25
$409.1M
$25.7M
Q3 25
$83.6M
$48.1M
Q2 25
$120.9M
$28.6M
Q1 25
$87.2M
$15.0M
Q4 24
$261.2M
$39.2M
Q3 24
$100.3M
$49.3M
Q2 24
$55.1M
$42.2M
Q1 24
$33.1M
$44.7M
Free Cash Flow
PLMR
PLMR
RGEN
RGEN
Q4 25
$409.0M
$17.6M
Q3 25
$83.6M
$43.4M
Q2 25
$120.8M
$21.5M
Q1 25
$87.1M
$11.4M
Q4 24
$260.9M
$33.6M
Q3 24
$100.1M
$42.3M
Q2 24
$37.4M
Q1 24
$36.4M
FCF Margin
PLMR
PLMR
RGEN
RGEN
Q4 25
161.4%
8.9%
Q3 25
34.2%
23.0%
Q2 25
59.4%
11.8%
Q1 25
49.9%
6.8%
Q4 24
167.5%
19.3%
Q3 24
67.4%
27.3%
Q2 24
24.3%
Q1 24
24.0%
Capex Intensity
PLMR
PLMR
RGEN
RGEN
Q4 25
0.1%
4.1%
Q3 25
0.0%
2.5%
Q2 25
0.0%
3.9%
Q1 25
0.0%
2.1%
Q4 24
0.2%
3.2%
Q3 24
0.1%
4.5%
Q2 24
0.0%
3.1%
Q1 24
0.0%
5.5%
Cash Conversion
PLMR
PLMR
RGEN
RGEN
Q4 25
1.93×
Q3 25
1.63×
3.23×
Q2 25
2.60×
1.92×
Q1 25
2.03×
2.57×
Q4 24
Q3 24
3.29×
Q2 24
2.14×
12.70×
Q1 24
1.26×
21.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons